Skip to main content

European Archives of Psychiatry and Clinical Neuroscience

Ausgabe 8/2023

Inhalt (20 Artikel)

Open Access Editorial

Shared Decision Making Assistant (SDMA) and other digital tools for choosing antipsychotics in schizophrenia treatment

Stefan Leucht, Spyridon Siafis, Alessandro Rodolico, Natalie L. Peter, Katharina Müller, Jakob Waibel, Wolfgang Strube, Alkomiet Hasan, Ingrid Bauer, Peter Brieger, John M. Davis, Johannes Hamann

Original Paper

Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia

Giuliana S. Zuccoli, Juliana M. Nascimento, Pedro M. Moraes-Vieira, Stevens K. Rehen, Daniel Martins-de-Souza

Open Access Original Paper

Schizophrenia polygenic risk score in psychosis proneness

Patricia Mas-Bermejo, Sergi Papiol, Marc Via, Paula Rovira, Pilar Torrecilla, Thomas R. Kwapil, Neus Barrantes-Vidal, Araceli Rosa

Original Paper

Significance of an altered lncRNA landscape in schizophrenia and cognition: clues from a case–control association study

Anirban Mukhopadhyay, Smita N. Deshpande, Triptish Bhatia, B. K. Thelma

Open Access Original Paper

Blood–brain barrier dysfunction and folate and vitamin B12 levels in first-episode schizophrenia-spectrum psychosis: a retrospective chart review

Mattia Campana, Lisa Löhrs, Johanna Strauß, Susanne Münz, Tatiana Oviedo-Salcedo, Piyumi Fernando, Isabel Maurus, Florian Raabe, Joanna Moussiopoulou, Peter Eichhorn, Peter Falkai, Alkomiet Hasan, Elias Wagner

Open Access Original Paper

Structure/function interrelationships and illness insight in patients with schizophrenia: a multimodal MRI data fusion study

Marie-Luise Otte, Mike M. Schmitgen, Nadine D. Wolf, Katharina M. Kubera, Vince D. Calhoun, Stefan Fritze, Lena S. Geiger, Heike Tost, Ulrich W. Seidl, Andreas Meyer-Lindenberg, Dusan Hirjak, Robert Christian Wolf

Original Paper

Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning

Nina B. Paul, Gregory P. Strauss, Jessica J. Gates-Woodyatt, Kimberly A. Barchard, Daniel N. Allen

Original Paper

Attenuated niacin response is associated with a subtype of first-episode drug-naïve psychosis characterized as serious negative symptoms

TianHong Zhang, RanPiao Gan, JiaHui Zeng, JiaYi Ye, YeGang Hu, LiHua Xu, YanYan Wei, XiaoChen Tang, ChunBo Li, HaiChun Liu, Tao Chen, JiJun Wang

Open Access Original Paper

Self-esteem in stabilized individuals with chronic schizophrenia: association with residual symptoms and cognitive functioning

Alex Hofer, Falko Biedermann, Alexandra Kaufmann, Georg Kemmler, Nicole M. Pfaffenberger, Nursen Yalcin-Siedentopf

Original Paper

Reinforcement learning profiles and negative symptoms across chronic and clinical high-risk phases of psychotic illness

Michael J. Spilka, Ian M. Raugh, Alysia M. Berglund, Katherine F. Visser, Gregory P. Strauss

Original Paper

Longitudinal evaluation on negative symptoms in young people at Ultra-High Risk (UHR) of psychosis: results from a 2-year follow-up study in a real-world care setting

Lorenzo Pelizza, Emanuela Leuci, Emanuela Quattrone, Silvia Azzali, Giuseppina Paulillo, Simona Pupo, Pietro Pellegrini, Marco Menchetti

Original Paper

History of learning disorders is associated with worse cognitive and functional outcomes in schizophrenia: results from the multicentric FACE-SZ cross-sectional dataset

Clément Dondé, Caroline Dubertret, Guillaume Fond, Myrtille Andre, Fabrice Berna, Laurent Boyer, Delphine Capdevielle, Isabelle Chereau, Nathalie Coulon, Jean-Michel Dorey, Sylvain Leignier, Pierre-Michel Llorca, David Misdrahi, Christine Passerieux, Baptiste Pignon, Romain Rey, Benoît Schorr, Franck Schürhoff, Mathieu Urbach, Mircea Polosan, Jasmina Mallet

Open Access Original Paper

Clustering of antipsychotic-naïve patients with schizophrenia based on functional connectivity from resting-state electroencephalography

Karen S. Ambrosen, Fanny Fredriksson, Simon Anhøj, Nikolaj Bak, Edwin van Dellen, Livia Dominicus, Cecilie K. Lemvigh, Mikkel E. Sørensen, Mette Ø. Nielsen, Kirsten B. Bojesen, Birgitte Fagerlund, Birte Y. Glenthøj, Bob Oranje, Lars K. Hansen, Bjørn H. Ebdrup

Open Access Original Paper

Fibre density and fibre-bundle cross-section of the corticospinal tract are distinctly linked to psychosis-specific symptoms in antipsychotic-naïve patients with first-episode schizophrenia

Tina D. Kristensen, Jayachandra M. Raghava, Martin W. Skjerbæk, Thijs Dhollander, Warda Syeda, Karen S. Ambrosen, Kirsten B. Bojesen, Mette Ø. Nielsen, Christos Pantelis, Birte Y. Glenthøj, Bjørn H. Ebdrup

Original Paper

Differences in olfactory dysfunction and its relationship with cognitive function in schizophrenia patients with and without auditory verbal hallucinations

Qianjin Wang, Honghong Ren, Zongchang Li, Jinguang Li, Lulin Dai, Min Dong, Jun Zhou, Jingqi He, Xiaogang Chen, Lin Gu, Ying He, Jinsong Tang

Original Paper

Attentional biases in facial emotion processing in individuals at clinical high risk for psychosis

Trevor F. Williams, Alex S. Cohen, Alvaro Sanchez-Lopez, Jutta Joormann, Vijay A. Mittal

Original Paper

Clinical and biological correlates of optical coherence tomography findings in schizophrenia

Ayse Kurtulmus, Cigdem Sahbaz, Ahmet Elbay, Eray Metin Guler, Gamze Sonmez Avaroglu, Abdurrahim Kocyigit, Mehmet Hakan Ozdemir, Ismet Kirpinar

Original Paper

Cerebral blood flow changes in schizophrenia patients with auditory verbal hallucinations during low-frequency rTMS treatment

Yuanjun Xie, Muzhen Guan, Zhongheng Wang, Zhujing Ma, Peng Fang, Huaning Wang

Original Paper

Network analysis of discrete emotional states measured via ecological momentary assessment in schizophrenia

Gregory P. Strauss, Farnaz Zamani-Esfahlani, Ian M. Raugh, Lauren Luther, Hiroki Sayama

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.